The current valuation score of Rallybio Corp is 9.02, ranking 63 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.68, which is -98.00% below the recent high of -0.23 and -29.51% above the recent low of -15.13.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.